Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany.

Abstract

OBJECTIVES To estimate the cost-effectiveness of etanercept (ETN) plus usual care (including NSAIDs) compared with usual care alone (including NSAIDs) in patients with severe AS in Germany. METHODS A mathematical model previously applied to the UK was adapted using resource use and cost data (for 2007) from the national database of the German… (More)
DOI: 10.1093/rheumatology/keq222

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics